Aims
To evaluate the association between beta-blocker (BB) prescription and long-term all-cause mortality after acute coronary syndrome (ACS), and to assess whether this varies across the left ventricular ejection fraction (LVEF) spectrum.
Methods and results
We analysed ACS patients from the retrospective multicentr...
E. Tsiartas, Sokratis Oikonomou, A. Iordanidou et al.· European Heart Journal Open· 0 citations
Heart failure with reduced ejection fraction (HFrEF), defined by a left ventricular ejection fraction ≤ 40%, remains a major global health challenge, associated with substantial morbidity, mortality, and impaired quality of life (QoL), particularly in patients with higher NYHA class. Sodium–glucose cotransporter‐2 (SGL...
V. Potoupni, A. Boulmpou, S. Maragkoudakis et al.· Clinical Cardiology· 0 citations
The low prevalence of symptomatic HF and low rate of HF-progression likely reflect effective monitoring and intervention at preclinical HF stages, and the substantial healthcare-burden highlights an unmet need regarding implementation of HF preventive management strategies in patients with T2D.
C. Georgiou, V. Bistola, A. Karavidas et al.· Journal of diabetes and its...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.